{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T00:35:52Z","timestamp":1793838952452,"version":"4.6.1"},"reference-count":46,"publisher":"BMJ","issue":"Suppl 2","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-003239"],"award-info":[{"award-number":["INV-003239"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ EBM"],"accepted":{"date-parts":[[2024,12,3]]},"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Health technology assessment (HTA) is a valuable tool for informing the efficient allocation of resources in healthcare. However, the resource-intensive nature of HTA can limit its application, especially in low-resource settings. Adapting HTA processes by assessing the available international evidence offers a pragmatic approach to provide evidence for decision-making where resources are constrained.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study piloted an adaptive HTA (aHTA) method to evaluate 10 cancer interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We arranged a joint collaboration with the International Decision Support Initiative and the National Cancer Grid in India to form a working group of clinicians and health economists. We conducted a rapid review of HTA reports and economic evaluations for ten prioritised common cancer interventions for breast, lung, and head and neck cancers. We extracted data on cost-effectiveness, conducted a price benchmarking analysis, estimated treatment costs and calculated the treatment\u2019s share of the national insurance family allowance. Finally, we determined through qualitative appraisal whether the intervention would likely to be considered cost-effective in the Indian context.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of the 10 interventions assessed, 9 had sufficient evidence to make determinations on the likely cost-effectiveness. Three were potentially cost-effective (one after a price discount and another by using the generic price), while five were not, and one was only cost-effective in a subgroup. One intervention required a full HTA due to remaining uncertainty. Information on the likely cost-effectiveness, clinical and safety benefits, and treatment costs was consistently found through publicly available evidence. Assessment methods were modified slightly across the 10 interventions, including expanding the data extraction criteria, updating the calculations and broadening the evidence retrieval.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The aHTA method is a feasible resource-sensitive alternative to traditional HTA for informing decision-making in resource-constrained settings when ample international data on cost-effectiveness for a given topic is available.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjebm-2023-112490","type":"journal-article","created":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T13:20:17Z","timestamp":1735824017000},"page":"s20-s28","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["Exploring adaptive health technology assessment for evaluating 10 cancer interventions: insights and lessons from a pilot study in India"],"prefix":"10.1136","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-0973","authenticated-orcid":false,"given":"Srobana","family":"Ghosh","sequence":"first","affiliation":[{"name":"Center for Global Development, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C S","family":"Pramesh","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manju","family":"Sengar","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Ranganathan","sequence":"additional","affiliation":[{"name":"Department of Anaesthesia, Tata Memorial Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5183-3959","authenticated-orcid":false,"given":"Francis","family":"Ruiz","sequence":"additional","affiliation":[{"name":"London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tabassum","family":"Wadasadawala","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Nayak","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayashree","family":"Thorat","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Apurva","family":"Ashok","sequence":"additional","affiliation":[{"name":"Tata Memorial Centre, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malkeet","family":"Singh","sequence":"additional","affiliation":[{"name":"Center for Global Development, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3045-1649","authenticated-orcid":false,"given":"Abha","family":"Mehndiratta","sequence":"additional","affiliation":[{"name":"Center for Global Development, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra","family":"Nemzoff","sequence":"additional","affiliation":[{"name":"Center for Global Development, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiral Anil","family":"Shah","sequence":"additional","affiliation":[{"name":"Center for Global Development, Washington, District of Columbia, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"2025112607301101000_30.Suppl_2.s20.1","unstructured":"Marshall SJ . Developing Countries Face Double Burden of Disease. World Health Organisation Bulletin, 2004."},{"key":"2025112607301101000_30.Suppl_2.s20.2","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2019050","article-title":"The double burden of malnutrition among adults in India: evidence from the National Family Health Survey-4 (2015-16)","volume":"41","author":"Dutta","year":"2019","journal-title":"Epidemiol Health"},{"key":"2025112607301101000_30.Suppl_2.s20.3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283385","article-title":"Socio-economic inequalities in burden of communicable and non-communicable diseases among older adults in India: Evidence from Longitudinal Ageing Study in India, 2017-18","volume":"18","author":"Kundu","year":"2023","journal-title":"PLoS ONE"},{"key":"2025112607301101000_30.Suppl_2.s20.4","unstructured":"The Global Cancer Observatory . Globocan 2020: India Fact Sheet 2020, Available: https:\/\/gco.iarc.fr\/today\/data\/factsheets\/populations\/356-india-fact-sheets.pdf"},{"key":"2025112607301101000_30.Suppl_2.s20.5","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.ijmr_1821_22"},{"key":"2025112607301101000_30.Suppl_2.s20.6","doi-asserted-by":"publisher","DOI":"10.1200\/JGO.17.00175"},{"key":"2025112607301101000_30.Suppl_2.s20.7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193320","article-title":"Economic burden of cancer in India: Evidence from cross-sectional nationally representative household survey, 2014","volume":"13","author":"Rajpal","year":"2018","journal-title":"PLoS One"},{"key":"2025112607301101000_30.Suppl_2.s20.8","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)70117-2"},{"key":"2025112607301101000_30.Suppl_2.s20.9","doi-asserted-by":"publisher","DOI":"10.4103\/0971-5851.142040"},{"key":"2025112607301101000_30.Suppl_2.s20.10","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdz309.003","article-title":"National Cancer Grid: a model for collaboration in cancer care and research","volume":"30","author":"Sengar","year":"2019","journal-title":"Ann Oncol"},{"key":"2025112607301101000_30.Suppl_2.s20.11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00077-2"},{"key":"2025112607301101000_30.Suppl_2.s20.12","unstructured":"National Cancer Grid . NCG Guidelines Manual National Cancer Grid, 2021. Available: https:\/\/tmc.gov.in\/ncg\/index.php\/guidelines\/guidelines-manual1"},{"key":"2025112607301101000_30.Suppl_2.s20.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002759","article-title":"The Ayushman Bharat Pradhan Mantri Jan Arogya Yojana and the path to universal health coverage in India: Overcoming the challenges of stewardship and governance","volume":"16","author":"Angell","year":"2019","journal-title":"PLoS Med"},{"key":"2025112607301101000_30.Suppl_2.s20.14","unstructured":"India Government . A cover of Rs. 5 Lakhs per family per year for secondary and tertiary care Official Website Ayushman Bharat Pradhan Mantri Jan Arogya Yojana National Health Authority, 2020. Available: https:\/\/pmjay.gov.in\/node\/4"},{"key":"2025112607301101000_30.Suppl_2.s20.15","doi-asserted-by":"crossref","unstructured":"Basavaiah G , Rent PD , Rent EG , et al . Financial impact of complex cancer surgery in India. J Glob Oncol 2018. doi:10.1200\/JGO.17.00151","DOI":"10.1200\/JGO.17.00151"},{"key":"2025112607301101000_30.Suppl_2.s20.16","doi-asserted-by":"crossref","first-page":"101259","DOI":"10.1016\/j.cegh.2023.101259","article-title":"Financial burden and coping strategies for cancer care in India","volume":"20","author":"Goyanka","year":"2023","journal-title":"Clin Epidemiol Glob Health"},{"key":"2025112607301101000_30.Suppl_2.s20.17","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1065737","article-title":"Financial toxicity of cancer treatment in India: towards closing the cancer care gap","volume":"11","author":"Prinja","year":"2023","journal-title":"Front Public Health"},{"key":"2025112607301101000_30.Suppl_2.s20.18","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.722927","article-title":"An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations","volume":"9","author":"Turner","year":"2021","journal-title":"Front Public Health"},{"key":"2025112607301101000_30.Suppl_2.s20.19","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462320000215"},{"key":"2025112607301101000_30.Suppl_2.s20.20","doi-asserted-by":"publisher","DOI":"10.4103\/ijmr.IJMR_115_19"},{"key":"2025112607301101000_30.Suppl_2.s20.21","unstructured":"National Health System Cost Database for India . National Health System Cost Database for India, Health care economic evaluation studies from India, Available: https:\/\/www.healtheconomics.pgisph.in\/costing_web\/index.php?action=pblctn_economics_studies"},{"key":"2025112607301101000_30.Suppl_2.s20.22","doi-asserted-by":"crossref","DOI":"10.1186\/s12962-021-00308-1","article-title":"Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making","volume":"19","author":"Teerawattananon","year":"2021","journal-title":"Cost Eff Resour Alloc"},{"key":"2025112607301101000_30.Suppl_2.s20.23","first-page":"569","article-title":"The Development of the Guide to Economic Analysis and Research (GEAR) Online Resource for Low- and Middle-Income Countries\u2019 Health Economics Practitioners: A Commentary","volume":"21","author":"Adeagbo","year":"2018","journal-title":"V Health"},{"key":"2025112607301101000_30.Suppl_2.s20.24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2020-004549","article-title":"Adaptive health technology assessment to facilitate priority setting in low- and middle-income countries","volume":"6","author":"Nemzoff","year":"2021","journal-title":"BMJ Glob Health"},{"key":"2025112607301101000_30.Suppl_2.s20.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2023.05.017"},{"key":"2025112607301101000_30.Suppl_2.s20.26","unstructured":"WH Organization . The Global Survey on HTA and Health Benefit Packages: Interactive Database and Findings, 2021. Available: https:\/\/www.who.int\/news-room\/events\/detail\/2021\/12\/16\/default-calendar\/global-survey-on-hta-database-findings"},{"key":"2025112607301101000_30.Suppl_2.s20.27","unstructured":"Norwegian Institute for Public Health . Technical Guidance for Health Technology Assessment in Low-and Middle-Income Countries, 2023. Available: https:\/\/www.fhi.no\/contentassets\/0f548deb25244305a1bab513f6f5f0e2\/hta-guidance-document-final.pdf"},{"key":"2025112607301101000_30.Suppl_2.s20.28","unstructured":"Canadian Agency for Drugs and Technologies in Health . About the Rapid Response Service Canada\u2019s Drug and Health Technology Agency, Available: https:\/\/www.cadth.ca\/about-rapid-response-service"},{"key":"2025112607301101000_30.Suppl_2.s20.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthpol.2013.07.019"},{"key":"2025112607301101000_30.Suppl_2.s20.30","unstructured":"Eunethta . EUnetHTA HTA Adaptation Toolkit, Available: https:\/\/www.eunethta.eu\/eunethta-hta-adaptation-toolkit\/"},{"key":"2025112607301101000_30.Suppl_2.s20.31","unstructured":"Overview of the Drug Reimbursement Process . National centre for pharmacoeconomics, ireland. n.d. Available: https:\/\/www.ncpe.ie\/submission-process\/overview-of-the-drug-reimbursement-process\/"},{"key":"2025112607301101000_30.Suppl_2.s20.32","unstructured":"International Decision Support Initiative (iDSI), Available: https:\/\/www.idsihealth.org"},{"key":"2025112607301101000_30.Suppl_2.s20.33","unstructured":"National Cancer Grid . NCG AHTA Process and Methods Guide, 2022. Available: https:\/\/tmc.gov.in\/ncg"},{"key":"2025112607301101000_30.Suppl_2.s20.34","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-014-0579-0","article-title":"PICO, PICOS and SPIDER: a comparison study of specificity and sensitivity in three search tools for qualitative systematic reviews","volume":"14","author":"Methley","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"2025112607301101000_30.Suppl_2.s20.35","unstructured":"The Cochrane Collaboration . Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0.2013. Available: https:\/\/training.cochrane.org\/handbook\/current"},{"key":"2025112607301101000_30.Suppl_2.s20.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2020.10.007"},{"key":"2025112607301101000_30.Suppl_2.s20.37","doi-asserted-by":"publisher","DOI":"10.1017\/S0266462314000543"},{"key":"2025112607301101000_30.Suppl_2.s20.38","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-015-0040-4","article-title":"Advancing knowledge of rapid reviews: an analysis of results, conclusions and recommendations from published review articles examining rapid reviews","volume":"4","author":"Featherstone","year":"2015","journal-title":"Syst Rev"},{"key":"2025112607301101000_30.Suppl_2.s20.39","doi-asserted-by":"crossref","unstructured":"Husereau D , Drummond M , Augustovski F , et al . CHEERS 2022 ISPOR Good Research Practices Task Force. Consolidated Health Economic Evaluation Reporting Standards 2022. Val Health 2022;35031096. doi:10.1016\/j.jval.2021.11.1351","DOI":"10.1016\/j.jval.2021.11.1351"},{"key":"2025112607301101000_30.Suppl_2.s20.40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2010.00771.x"},{"key":"2025112607301101000_30.Suppl_2.s20.41","unstructured":"Office of Health Economics . Do NICE\u2019s Decision Outcomes Impact International HTA Decision-Making, 2023. Available: https:\/\/www.ohe.org\/publications\/nice-enough-do-nices-decision-outcomes-impact-international-hta-decision-making"},{"key":"2025112607301101000_30.Suppl_2.s20.42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232873","article-title":"Process evaluation of health system costing \u2013 Experience from CHSI study in India","volume":"15","author":"Prinja","year":"2020","journal-title":"PLoS ONE"},{"key":"2025112607301101000_30.Suppl_2.s20.43","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012987","article-title":"National hospital costing systems matter for universal healthcare: the India PM-JAY experience","volume":"8","author":"Prinja","year":"2023","journal-title":"BMJ Glob Health"},{"key":"2025112607301101000_30.Suppl_2.s20.44","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01738-x"},{"key":"2025112607301101000_30.Suppl_2.s20.45","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012277","article-title":"Validating the rigour of adaptive methods of economic evaluation","volume":"8","author":"Chauhan","year":"2023","journal-title":"BMJ Glob Health"},{"key":"2025112607301101000_30.Suppl_2.s20.46","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1200\/GO.20.00122","article-title":"Cancer Statistics, 2020: Report From National Cancer Registry Programme, India","volume":"6","author":"Mathur","year":"2020","journal-title":"JCO Glob Oncol"}],"container-title":["BMJ Evidence-Based Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjebm-2023-112490","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T15:30:40Z","timestamp":1764171040000},"score":1,"resource":{"primary":{"URL":"https:\/\/ebm.bmj.com\/lookup\/doi\/10.1136\/bmjebm-2023-112490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":46,"journal-issue":{"issue":"Suppl 2","published-online":{"date-parts":[[2025,11,26]]},"published-print":{"date-parts":[[2025,12]]}},"alternative-id":["10.1136\/bmjebm-2023-112490"],"URL":"https:\/\/doi.org\/10.1136\/bmjebm-2023-112490","relation":{},"ISSN":["2515-446X","2515-4478"],"issn-type":[{"value":"2515-446X","type":"print"},{"value":"2515-4478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]}}}